Home > Insider Trading > Filing (0000950170-24-074869)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1861560	Nuvalent Inc.	NUVL	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1907812	Emily Conley	C/O Nuvalent, Inc. One Broadway, 14Th Floor Cambridge MA 02142		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Acquisiton	2024-06-14	5,000	$13.79	7,507	No	4	M	Direct
Class A Common Stock	Disposition	2024-06-14	4,777	$77.52	2,730	No	4	S	Direct
Class A Common Stock	Disposition	2024-06-14	223	$78.31	2,507	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Stock Option (Right to Buy)	Disposition	2024-06-14	5,000	$0.00	5,000	$13.79

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
31,667		2032-02-02	No	4	M	Direct

Footnotes

These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2023.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.93 to $77.81, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) of this Form 4.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.87 to $78.71, inclusive.
The shares underlying this option have vested or shall vest in equal monthly installments over the three years following February 2, 2022, subject to continued service to Nuvalent, Inc. through the applicable vesting date.